Association of serum miR-99a level and metabolic dysfunction-associated steatotic liver disease, serum mTOR levels in patients with type 2 diabetes mellitus
These data highlight a potential role for miR-99a as a regulator of the comorbid incidence of T2DM and MASLD, suggesting that measuring the levels of miR-99a can effectively predict the risk of MASLD in those with T2DM.
Authors
- Jing Liu (ORCID: https://orcid.org/0000-0002-3311-0818)
- Panpan Jiang
- Yaqiang Cui
- Yuqiong Zuo
- Yangyang Zhang (ORCID: https://orcid.org/0000-0003-3754-8291)
- Cheng Qian (ORCID: https://orcid.org/0000-0003-1500-9991)
- Jinxing Quan (ORCID: https://orcid.org/0000-0002-4517-3904)
- Yanxia Bao
Institutions
- Gansu Agricultural University (CN)
- Gansu Provincial Hospital (CN)
- Ningxia Medical University (CN)
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3389/fendo.2025.1724108
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province